Trial Details

COMPLETED
Basic Information
Clinical ID c3533
Identifier NCT01890837
Trial Title Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS)
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Irritable Bowel Syndrome|Digestive System Diseases|Gastrointestinal Diseases|Intestinal Diseases|Abdominal Pain
Interventions DRUG: Daikenchuto (TU-100)|DRUG: Placebo
Participant Information
Sponsor Tsumura USA
City Rochester
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1|PHASE2
Time Information
Start Date 2013-08
Primary Completion Date 2015-03
Completion Date 2015-03